Seelos Therapeutics Announces the Selection of SLS-002 (intr

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Vietnam , Republic Of , Iraq , New York , Iraqi , Americans , Mike Moyer , Anthony Marciano , Raj Mehra , Tim Whitaker , Agency For Healthcare Research , Nasdaq , Exchange Commission , Us Army Medical Department , Brain Health Project Management Office , Us Services , Us Army Medical Research , Defense Health Agency , Lifesci Advisors , Seelos Therapeutics Inc , Us Special , Department Of Defense , Us Department Of Veterans Affairs , Us Department Of Defense , Us Army Medical Materiel Development Activity , Treatment Program , Javelin Pharmaceuticals Inc Hospira , Drug Administration , Prnewswire Seelos Therapeutics Inc , Drug Treatment Program , Warfighter Readiness , Medical Materiel Development , Chief Executive Officer , Platform Trial , Columbia Suicide Severity Rating Scale , Chief Medical Officer , Veterans Affairs , World War , Korean War , Vietnam War , Persian Gulf War , Desert Storm , Operations Iraqi Freedom , Crisis Lifeline , Acute Suicidal Ideation , Major Depressive Disorder , Post Traumatic Stress , Javelin Pharmaceuticals , Healthcare Research , Medical Materiel Development Activity , Medical Research , Development Command , Medical Department , Joint Staff , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Sci Advisors ,